ARCHIVES

ODAC Recommends Femara Campath For FDA Approval.

This article is from The Cancer Letter archive.

Vol. 27 No. 01 | January 5, 2001

Download PDF Visit The Full Archive

Related Articles

NCI Says Sponsored Meetings Must Be Held In Smoke-Free Localities As of Jan. 1.

July 21, 2006

In Brief: Relocation Of NCI Offices Nearly Complete; Hungary’s Eckhardt UICC President elect

November 4, 1988

Congress Passes NIH Reauthorization.

December 15, 2006

Disease Oriented Programs Must Be Coordinated: Rabson

October 15, 1976

In Brief: Reviewed CCOP Applications Won’t Be Funded; Potter Recruiting For New Medical Oncology Chief

September 30, 1983

Zaltrap Economics 101: The Pricing And Repricing of an Expensive Drug

November 16, 2012